Adamis Pharmaceuticals Corporation ADMP
0.78 +0.78
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 4.76M | 2.21M | 2.78M | 22.11M | 15.09M | |
| -1.43M | -4.66M | -3.55M | 6.64M | 5.29M | |
| -25.06M | -32.07M | -36.34M | -29.35M | -39.46M | |
| -26.48M | -45.83M | -49.39M | -27.51M | -39.01M | |
| -12.60 | -22.40 | -44.80 | -36.40 | -70.00 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 1.11M | 23.25M | 6.75M | 8.81M | 19.27M | |
| 10.93M | 38.30M | 30.87M | 47.84M | 58.36M | |
| 11.58M | 12.42M | 27.37M | 14.84M | 11.67M | |
| 342.56K | 692.43K | 4.21M | 4.08M | 2.58M | |
| -808.07K | 25.88M | 3.50M | 33.00M | 46.69M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -25.90M | -37.79M | -20.90M | -19.89M | -32.66M | |
| 3.48M | 282.74K | -946.21K | -2.87M | -3.54M | |
| 285.00K | 53.94M | 19.89M | 12.29M | 37.13M | |
| -680.42K | -1.22M | -450.47K | -2.87M | -3.54M | |
| -22.13M | 16.43M | -1.96M | -10.46M | 938.94K |